Competition

  • October 28, 2026

    Fla. Appeals Court Says Porsche Must Face $300M Suit

    A Florida state appeals court Wednesday affirmed a ruling that German automaker Porsche AG must face a $300 million lawsuit brought by The Collection LLC, a Miami luxury car dealership accusing the carmaker of strong-arm tactics by withholding inventory over a disagreement to build a new facility.

  • October 28, 2026

    Full Fed. Circ. Won't Eye Network IP Ruling In Amazon's Favor

    The full Federal Circuit on Wednesday declined to take up a split panel ruling that let Amazon escape infringement claims stemming from a network patent held by AlterWAN Inc.

  • October 28, 2026

    FEMA Contractors Say No-Poach, Wage-Fixing Suit Still Faulty

    Fluor Federal Services and some of its federal disaster response subcontractors urged a Florida federal judge Tuesday to definitively end a proposed class action accusing them of agreeing to fix wages and avoid hiring each other's workers, arguing the amended complaint still doesn't fix shortcomings identified by the court.

  • October 28, 2026

    American, JetBlue Oppose Class Cert. For Northeast Alliance

    American Airlines and JetBlue are opposing a class certification bid from flyers suing over a past alliance between the airlines, telling a New York federal court the motion relies on a flawed economic model because there's no evidence of the pact causing higher fares.

  • October 28, 2026

    Sanofi Settles Insulin Pen Antitrust Suit, Avoiding Trial

    Sanofi-Aventis US and a group of drug wholesalers have told a Massachusetts federal judge they have reached a settlement to resolve long-running antitrust litigation alleging that the drugmaker improperly sought to thwart competition for its single-use insulin injector pen.

  • October 28, 2026

    Celgene Defends Dismissal Of Cancer Drug Antitrust Suit

    Bristol-Myers Squibb Co. and its subsidiary Celgene Corp. urged the Second Circuit to uphold the dismissal of health plans' proposed antitrust class action alleging that the drugmaker fraudulently obtained patents for the cancer drug Pomalyst, saying it properly disclosed materials to the patent office and filed valid patent infringement lawsuits against generic-drug makers. 

  • October 28, 2026

    RealPage Says NY Can't Get Redo For Blocked Software Law

    Property management software company RealPage Inc. has urged a New York federal court to stand by a prior ruling that temporarily blocked New York's attorney general from enforcing part of a state law that aims to stop landlords from using revenue management software that allows them to engage in rent price-fixing.

  • October 28, 2026

    Netherlands Blocks Unilever Deal To Unload Dutch Brand

    The Dutch competition regulator has decided to block the sale by multinational consumer goods giant Unilever PLC of Dutch brand Unox to Zwanenberg, almost two years after the deal was announced.

  • October 27, 2026

    Anthropic's 'Existential Risks' Warning Sets Stage For AI IPOs

    Anthropic PBC's registration statement includes more than 90 pages of risk disclosures for prospective investors ahead of the Claude developer's planned public offering, including "existential risks to humanity" posed by advanced artificial intelligence and a corporate governance structure the company warns may make it difficult for voting shareholders to replace directors and managers.

  • October 27, 2026

    CVS Says Faulty Medicare Advantage Ratings Will Cost It $2B

    Insurance giant CVS Health sued the Trump administration in Georgia federal court Monday, alleging that federal quality ratings for its Medicare Advantage contracts were calculated using methods a judge rejected last year and will cost the company more than $2 billion in bonus payments and rebates in 2028.

  • October 27, 2026

    Spotify Beats Rapper's Bot-Streaming Royalty Suit For Good

    A California federal judge has permanently dismissed rapper RBX's proposed class action accusing Spotify of failing to stop bots that distort streaming data and royalty payments, finding the platform had no duty to protect artists from third-party misconduct and rejecting his theory that Spotify selectively enforced its anti-fraud measures in favor of popular acts.

  • October 27, 2026

    FCC OKs Amazon's $11.6B Globalstar Satellite Buy

    The Federal Communications Commission has signed off on Amazon.com Inc.'s $11.6 billion plan to buy U.S. satellite company Globalstar Inc., bringing the e-commerce behemoth one step closer to expanding its nascent satellite internet business.

  • October 27, 2026

    5-Hour Energy Sellers Ask 9th Circ. To Revive Antitrust Fight

    Family-owned wholesalers urged the Ninth Circuit to revive antitrust claims Tuesday alleging 5-Hour Energy violated price discrimination law by providing Costco with disproportionate promotional support, arguing the court wrongly applied an "extremely narrow view of antitrust injury."

  • October 27, 2026

    AI Users Say SpaceXAI Can't Split, Arbitrate Slowdown Suit

    Artificial intelligence users urged a California federal judge Tuesday not to let SpaceXAI separate itself from their proposed class action accusing it, Anthropic, OpenAI and Google of violating antitrust law through their "pace the frontier" collaboration slowing down AI development, attacking the Elon Musk-owned company's efforts to invoke arbitration.

  • October 27, 2026

    Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More

    Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.

  • October 27, 2026

    Daily Mail, Publishers Fight Google's 'Multi-Year Delay'

    Gannett, the Daily Mail and a certified class of website publishers urged a New York federal judge Monday not to let Google pause a scheduled advertising placement technology trial, arguing in twin briefs that the U.S. Department of Justice's antitrust win is strong and Google's appeal won't disrupt the multidistrict litigation.

  • October 27, 2026

    Disney Says Fubo Can't Appeal Arbitration Order

    Disney has asked a California federal court to deny Fubo subscribers certification of an interlocutory appeal as they fight an order to arbitrate their case over streaming rates, saying they failed to satisfy the requirements for it.

  • October 27, 2026

    ​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial

    A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.

  • October 27, 2026

    Playground Equipment Makers Abandon Deal After FTC Action

    PlayPower has abandoned its planned purchase of fellow private equity-backed playground equipment maker BCI Burke after the Federal Trade Commission and a dozen states moved to challenge the deal.

  • October 27, 2026

    CMA Seeks Views On Prologis' £14B Segro Deal

    The antitrust regulator called Tuesday for input on how U.S. warehouse business Prologis' £14 billion ($19 billion) planned acquisition of British rival Segro might harm competition in U.K. markets.

  • October 27, 2026

    Amazon Can Seek Seller Evidence In £2.7B Data Misuse Claim

    Amazon can approach sellers for evidence to fight a £2.7 billion ($3.6 million) class action over alleged competition abuses, but a tribunal said the technology giant must inform them that refusing to cooperate will not jeopardize their business relationship.

  • October 26, 2026

    Google Says DOJ Overreaching With Proposed Antitrust Fixes

    Google has told a D.C. federal court that the U.S. Department of Justice and state enforcers are trying to force it into unreasonable antitrust measures that go beyond what the court imagined when it handed down its remedies order in the monopolization suit.

  • October 26, 2026

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

    A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated" clinical trials and "false superiority messages," ruling that Novo Nordisk hasn't shown it would be irreparably harmed.

  • October 26, 2026

    Attys Seek $20M Award For $59M Fragrance Price-Fix Deals

    Fragrance ingredient buyers and the attorneys who helped them secure $59 million in price-fixing settlements are now asking a New Jersey federal court for final approval and the green light to set aside a third of those funds for legal counsel.

  • October 26, 2026

    Data-Scraping Co. Says Reddit Must Face Counterclaims

    A data-scraping company accused of acting like "would-be bank robbers" in taking in copyrighted data from Reddit that is then used to train AI said in a brief defending its antitrust counterclaims that the content in question actually belongs to Reddit users, and that Reddit anticompetitively restricts access to it.

Expert Analysis

  • 4 Paths To AI Safety Coordination Amid Antitrust Debate

    Author Photo

    Frontier artificial intelligence companies have more room for collective safety work than the debate over an antitrust waiver suggests, with several existing avenues providing different degrees of protection and oversight, says Evan Miller at V&E.

  • Time Is On Payment Processors' Side As Deal Dynamics Shift

    Author Photo

    As payment processors increasingly use timing and volume to gain leverage, merchants should negotiate payment processing agreements well before renewal or migration deadlines, ensuring proper benchmarking, reserve, data, termination and transition terms are in place, says James Alexander at Reed Smith.

  • How FTC's $20B Amazon Suit May Shake Up Ad Enforcement

    Author Photo

    Gonzalo Mon at Kelley Drye discusses the significance of the Federal Trade Commission's recent suit against Amazon for allegedly overcharging advertising customers more than $20 billion, the company's potential defenses, and the context of rapidly evolving digital advertising technology.

  • Series

    Law School's Missed Lessons: Cultivating Good Judgment

    Author Photo

    Law schools generally overlook the role that solid judgment skills play in real-world practice, but attorneys can bridge the gap by strengthening their abilities to assess a case’s strengths and weaknesses, develop and execute effective strategies, and provide clear recommendations to clients, says Manny Caixeiro at Venable.

  • DOJ Letter Rescission Portends Proxy Firm Antitrust Risk

    Author Photo

    The U.S. Justice Department's recent withdrawal of its 1987 business review letter issued to Institutional Shareholder Services, which shielded certain proxy advisory activities from anticompetitive enforcement, likely foreshadows renewed antitrust scrutiny of proxy advisory firms, say attorneys at Paul Weiss.

  • What Meta Damages Ruling Means For Data Abuse Claims

    Author Photo

    The recent Court of Appeal ruling in Meta v. Gormsen found that user damages might be awarded for abuse of a dominant market position, raising the possibility of a novel type of competition claim against U.K. companies accused of misusing personal data, say lawyers at Macfarlanes.

  • FTC Focus: A Shift In The Pricing Disclosure Terrain

    Author Photo

    Recent state and Federal Trade Commission developments spotlight materially different ways in which personalized pricing might be addressed, which could result in an increasingly fragmented regulatory landscape in which businesses face differing disclosure obligations and substantive restrictions depending upon the jurisdiction, say attorneys at Proskauer.

  • Attorneys Using AI May Have Ethical Duty To Redact Docs

    Author Photo

    The trajectory of legal ethics guidance in recent years strongly suggests that as redaction technology becomes more accessible, the failure to use it when uploading highly confidential materials into artificial intelligence tools will become increasingly difficult to defend as reasonable, say attorneys at Lewis Brisbois.

  • Series

    Juggling And Unicycling Make Me A Better Lawyer

    Author Photo

    Because I juggle (sometimes with fire) and ride the unicycle, friends and family used to joke that I should join the circus, but I pursued the practice of law instead and learned that my hobbies benefit my profession in several important ways, says Morgan Eddy at Smith Currie.

  • Teva MDL Loss Shows DPAs Can Return To Haunt Civil Suits

    Author Photo

    Teva’s recent partial summary judgment loss in antitrust multidistrict litigation reinforces the importance of carefully scrutinizing any statement of facts a company admits to in a deferred prosecution agreement, and illustrates the potential costs of resolving a criminal investigation this way, say attorneys at Sheppard.

  • 2 ECJ Rulings Give Guidance On Sport Agent Regs

    Author Photo

    The European Court of Justice recently settled two long-running disputes, Rogon and RRC Sports, by finding that the antitrust rules governing these leagues offer exceptions for regulating players' agents, and offering a path for sports associations to implement rules controlling services ancillary to their sport, say lawyers at Skadden.

  • Deal Termination Lessons From Verisk Merger Review Ruling

    Author Photo

    The Delaware Chancery Court’s recent ruling that Verisk Analytics forfeited its right to terminate a deal that was facing a second information request from the Federal Trade Commission illustrates the danger of information gaps between client and counsel and the risks of "willful conduct" language in merger agreements, say attorneys at HSF Kramer.

  • Prepping Health Businesses For Sale In A Data-Driven Market

    Author Photo

    In a thinner market for healthcare transactions, with both regulators and buyers using artificial intelligence to inspect data in great detail, the margin for error in sellers' financials and legal diligence has narrowed, requiring more proactive compliance efforts, says Cody Dumas at FBFK Law.

  • Series

    Ballet Makes Me A Better Lawyer

    Author Photo

    A lifetime of learning and performing ballet taught me that success — whether in dance or practicing law — comes only through hours of thorough preparation, boundless energy and relentless effort, says Sharon Katz-Pearlman at Greenberg Traurig.

  • Drug Rulings Clarify Pricing Test And Penalty Reviews

    Author Photo

    The Court of Appeals’ recent drug price rulings in Pfizer v. Competition and Markets Authority and Auden Mckenzie v. CMA are both notable for how the court settled the legal test for excessive pricing, as well as for how it has restated the Competition Appeal Tribunal’s obligations when reviewing penalties, say lawyers at Wilson Sonsini.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.